Open Access

1,25‑Dihydroxyvitamin D3 enhances the susceptibility of anaplastic thyroid cancer cells to adriamycin‑induced apoptosis by increasing the generation of reactive oxygen species

  • Authors:
    • Ting Zhang
    • Liang He
    • Wei Sun
    • Yuan Qin
    • Ping Zhang
    • Hao Zhang
  • View Affiliations

  • Published online on: July 25, 2019     https://doi.org/10.3892/mmr.2019.10530
  • Pages: 2641-2648
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Anaplastic thyroid cancer (ATC) is a very aggressive malignancy that is resistant to various types of chemotherapy in humans. Most patients with late‑stage ATC cannot undergo surgery and receive chemotherapy drugs. The present study investigated the influence of 1,25‑dihydroxyvitamin D3 (1,25(OH)2D3) pretreatment on adriamycin (ADM) chemotherapy efficacy in the 8305c and 8505c ATC cell lines. The apoptotic effects of ADM on ATC cells pretreated with 1,25(OH)2D3 were evaluated. Cell viability was identified by using the Cell Counting Kit‑8 assay. Apoptosis was assessed by flow cytometry and staining with Hoechst 33342. The expression of the apoptotic protein cleaved caspase‑3 was tested with a colorimetric assay kit and by western blotting. Reactive oxygen species (ROS) generation was assessed with the antioxidant N‑acetyl‑L‑cysteine (NAC) and the assay H2‑DCFDA. In addition, ROS production could be reversed by NAC treatment. The present study demonstrated that 1,25(OH)2D3 enhanced ADM‑induced apoptosis in 8305c and 8505c cell lines. Furthermore, 1,25(OH)2D3 improved the ADM‑induced ROS production and expression of cleaved caspase‑3. NAC treatment inhibited the expression of cleaved caspase‑3 in ATC cells, and reduced apoptosis in cells that were pretreated with 1,25(OH)2D3 and ADM. These results demonstrated that 1,25(OH)2D3 may enhance ADM‑induced apoptosis by increasing ROS generation in ATC cells.

References

1 

Kasmann L, Bolm L, Janssen S and Rades D: Prognostic factors for survival in patients treated with multimodal therapy for anaplastic thyroid cancer. Anticancer Res. 36:4697–4700. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Nagaiah G, Hossain A, Mooney CJ, Parmentier J and Remick SC: Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol. 2011:5423582011. View Article : Google Scholar : PubMed/NCBI

3 

Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, et al: American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 22:1104–1139. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Akaishi J, Sugino K, Kitagawa W, Nagahama M, Kameyama K, Shimizu K and Ito K and Ito K: Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid. 21:1183–1189. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Jiménez-Fonseca P, Gómez Saez JM, Santamaria Sandi J, Capdevila J, Navarro Gonzalez E, Zafon Llopis C, Ramón Y, Cajal Asensio T, Riesco-Eizaguirre G, Grande E and Galofré JC: Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma. Clin Transl Oncol. 19:12–20. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Kebebew E, Greenspan FS, Clark OH, Woeber KA and McMillan A: Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 103:1330–1335. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Mitchell AL, Gandhi A, Scott-Coombes D and Perros P: Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 130:S150–S160. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Smallridge RC: Approach to the patient with anaplastic thyroid carcinoma. J Clin Endocrinol Metab. 97:2566–2572. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, et al: Anaplastic thyroid carcinoma, version 2.2015. J Natl Compr Canc Netw. 13:1140–1150. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Aiken MJ, Suhag V, Garcia CA, Acio E, Moreau S, Priebat DA, Chennupati SP and Van Nostrand D: Doxorubicin-induced cardiac toxicity and cardiac rest gated blood pool imaging. Clin Nucl Med. 34:762–767. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Yang L, Wu L, Du S, Hu Y, Fan Y and Ma J: 1,25(OH)2D3 inhibits high glucose-induced apoptosis and ROS production in human peritoneal mesothelial cells via the MAPK/P38 pathway. Mol Med Rep. 14:839–844. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Ma Y, Trump DL and Johnson CS: Vitamin D in combination cancer treatment. J Cancer. 1:101–107. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Xian M, Cao H, Cao J, Shao X, Zhu D, Zhang N, Huang P, Li W, Yang B, Ying M and He Q: Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis. Int J Cancer. 141:1029–1041. 2017. View Article : Google Scholar : PubMed/NCBI

14 

Chaudhry M, Sundaram S, Gennings C, Carter H and Gewirtz DA: The vitamin D3 analog, ILX-23-7553, enhances the response to adriamycin and irradiation in MCF-7 breast tumor cells. Cancer Chemother Pharmacol. 47:429–436. 2001. View Article : Google Scholar : PubMed/NCBI

15 

Hanušová V, Caltová K, Svobodová H, Ambrož M, Skarka A, Murínová N, Králová V, Tomšík P and Skálová L: The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice. Biomed Pharmacother. 95:828–836. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Aung LHH, Li R, Prabhakar BS and Li P: Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l-mediated mitochondrial fission. J Cell Mol Med. 21:3394–3404. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Sherman EJ, Lim SH, Ho AL, Ghossein RA, Fury MG, Shaha AR, Rivera M, Lin O, Wolden S, Lee NY and Pfister DG: Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: A critical re-evaluation including uniform pathologic review. Radiother Oncol. 101:425–430. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Garg M, Kanojia D, Mayakonda A, Ganesan TS, Sadhanandhan B, Suresh S, S S, Nagare RP, Said JW, Doan NB, et al: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin. Sci Rep. 7:97492017. View Article : Google Scholar : PubMed/NCBI

19 

Sharma V, Fretwell D, Crees Z, Kerege A and Klopper JP: Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism. Thyroid. 20:1103–1111. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Clinckspoor I, Verlinden L, Overbergh L, Korch C, Bouillon R, Mathieu C, Verstuyf A and Decallonne B: 1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer. J Steroid Biochem Mol Biol. 124:1–9. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Chiang KC, Kuo SF, Chen CH, Ng S, Lin SF, Yeh CN, Chen LW, Takano M, Chen TC, Juang HH, et al: MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential. Cancer Lett. 369:76–85. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Wang Z, Wang J, Xie R, Liu R and Lu Y: Mitochondria-derived reactive oxygen species play an important role in Doxorubicin-induced platelet apoptosis. Int J Mol Sci. 16:11087–11100. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Rogalska A, Gajek A, Szwed M, Jozwiak Z and Marczak A: The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: A comparison with the effect of doxorubicin. Toxicol In Vitro. 25:1712–1720. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Atashi F, Modarressi A and Pepper MS: The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: A review. Cells Dev. 24:1150–1163. 2015. View Article : Google Scholar

25 

Zhang L, Wang G, Chen X, Xue X, Guo Q, Liu M and Zhao J: Formyl peptide receptors promotes neural differentiation in mouse neural stem cells by ROS generation and regulation of PI3K-AKT signaling. Sci Rep. 7:2062017. View Article : Google Scholar : PubMed/NCBI

26 

Blanco J, Tomás-Hernández S, García T, Mulero M, Gómez M, Domingo JL and Sánchez DJ: Oral exposure to silver nanoparticles increases oxidative stress markers in the liver of male rats and deregulates the insulin signalling pathway and p53 and cleaved caspase 3 protein expression. Food Chem Toxicol. 115:398–404. 2018. View Article : Google Scholar : PubMed/NCBI

27 

Zhou D, Shao L and Spitz DR: Reactive oxygen species in normal and tumor stem cells. Adv Cancer Res. 122:1–67. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Redza-Dutordoir M and Averill-Bates DA: Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 1863:2977–2992. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Pan WY, Lin KJ, Huang CC, Chiang WL, Lin YJ, Lin WC, Chuang EY, Chang Y and Sung HW: Localized sequence-specific release of a chemopreventive agent and an anticancer drug in a time-controllable manner to enhance therapeutic efficacy. Biomaterials. 101:241–250. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Bondza-Kibangou P, Millot C, El Khoury V and Millot JM: Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D3 and seocalcitol in HL60 cells. Oncol Rep. 18:1513–1519. 2007.PubMed/NCBI

31 

Teixeira TM, da Costa DC, Resende AC, Soulage CO, Bezerra FF and Daleprane JB: Activation of Nrf2-antioxidant signaling by 1,25-Dihydroxycholecalciferol prevents leptin-induced oxidative stress and inflammation in human endothelial cells. J Nutr. 147:506–513. 2017. View Article : Google Scholar : PubMed/NCBI

32 

Rogalska A, Koceva-Chyła A and Jóźwiak Z: Aclarubicin-induced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines. Chem Biol Interact. 176:58–70. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Gillissen B, Richter A, Richter A, Preissner R, Schulze-Osthoff K, Essmann F and Daniel PT: Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma. J Biol Chem. 292:6478–6492. 2017. View Article : Google Scholar : PubMed/NCBI

34 

Guo N and Peng Z: MG132, a proteasome inhibitor, induces apoptosis in tumor cells. Asia Pac J Clin Oncol. 9:6–11. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 20 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhang, T., He, L., Sun, W., Qin, Y., Zhang, P., & Zhang, H. (2019). 1,25‑Dihydroxyvitamin D3 enhances the susceptibility of anaplastic thyroid cancer cells to adriamycin‑induced apoptosis by increasing the generation of reactive oxygen species. Molecular Medicine Reports, 20, 2641-2648. https://doi.org/10.3892/mmr.2019.10530
MLA
Zhang, T., He, L., Sun, W., Qin, Y., Zhang, P., Zhang, H."1,25‑Dihydroxyvitamin D3 enhances the susceptibility of anaplastic thyroid cancer cells to adriamycin‑induced apoptosis by increasing the generation of reactive oxygen species". Molecular Medicine Reports 20.3 (2019): 2641-2648.
Chicago
Zhang, T., He, L., Sun, W., Qin, Y., Zhang, P., Zhang, H."1,25‑Dihydroxyvitamin D3 enhances the susceptibility of anaplastic thyroid cancer cells to adriamycin‑induced apoptosis by increasing the generation of reactive oxygen species". Molecular Medicine Reports 20, no. 3 (2019): 2641-2648. https://doi.org/10.3892/mmr.2019.10530